Following the observation of altered expression levels of USP35, USP36, USP37, USP47, USP49, and OTUD6B in response to cisplatin treatment in lung cancer cells, both at the mRNA and protein levels, we sought to explore their significance in lung cancer. Here, USP36 is linked to lung carcinoma.